Published in PLoS Pathog on October 10, 2013
Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine | NCT00210288
Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. J Hepatol (2015) 1.47
CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep (2014) 1.28
Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol (2015) 1.23
Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol (2014) 1.19
MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol (2014) 1.13
Check MAIT. J Immunol (2014) 1.03
Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8⁺ T cells. PLoS One (2014) 0.97
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. J Immunol (2015) 0.96
Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog (2015) 0.94
Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis (2014) 0.94
CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol (2015) 0.91
High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells. Immunology (2015) 0.91
The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Front Immunol (2015) 0.90
MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev (2015) 0.89
Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells. J Biol Chem (2015) 0.87
CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS One (2014) 0.87
Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest (2015) 0.87
Respiratory syncytial virus infection, TLR3 ligands, and proinflammatory cytokines induce CD161 ligand LLT1 expression on the respiratory epithelium. J Virol (2013) 0.86
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool. Immunol Rev (2015) 0.86
MAIT cells are activated during human viral infections. Nat Commun (2016) 0.86
Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nat Commun (2016) 0.82
Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus. PLoS Pathog (2014) 0.81
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates. Mucosal Immunol (2016) 0.81
Evolution of nonclassical MHC-dependent invariant T cells. Cell Mol Life Sci (2014) 0.80
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out. Front Immunol (2015) 0.80
MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Front Immunol (2015) 0.80
A prominent role for invariant T cells in the amphibian Xenopus laevis tadpoles. Immunogenetics (2014) 0.80
MAIT cells: new guardians of the liver. Clin Transl Immunology (2016) 0.79
Mucosal-Associated Invariant T Cells in the Human Gastric Mucosa and Blood: Role in Helicobacter pylori Infection. Front Immunol (2015) 0.79
Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases. World J Stem Cells (2016) 0.78
Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology (2016) 0.78
Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A (2017) 0.78
The role of mucosal-associated invariant T cells in infectious diseases. Immunology (2016) 0.77
Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity. J Leukoc Biol (2016) 0.77
Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells. J Immunol (2016) 0.76
Innate-like lymphocytes in intestinal infections. Curr Opin Infect Dis (2015) 0.75
Targeting Innate-Like T Cells in Tuberculosis. Front Immunol (2016) 0.75
Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep (2016) 0.75
MAIT cells promote inflammatory monocyte differentiation into dendritic cells during pulmonary intracellular infection. J Exp Med (2016) 0.75
Expression and trafficking of MHC related protein 1 (MR1). Immunology (2017) 0.75
Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells. Front Immunol (2017) 0.75
Close Encounters of Lymphoid Cells and Bacteria. Front Immunol (2016) 0.75
The role of liver sinusoidal cells in local hepatic immune surveillance. Clin Transl Immunology (2016) 0.75
Structure and function of the non-classical major histocompatibility complex molecule MR1. Immunogenetics (2016) 0.75
Differential Effect of Cytomegalovirus Infection with Age on the Expression of CD57, CD300a, and CD161 on T-Cell Subpopulations. Front Immunol (2017) 0.75
The TLR9 signaling pathway regulates MR1-mediated bacterial antigen presentation in B cells. Immunology (2017) 0.75
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol (2017) 0.75
The MAIT conundrum - how human MAIT cells distinguish bacterial colonization from infection in mucosal barrier tissues. Immunol Lett (2017) 0.75
Human mucosal-associated invariant T (MAIT) cells possess capacity for B-cell help. J Leukoc Biol (2017) 0.75
TLR signaling. Cell Death Differ (2006) 9.24
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Protein delivery into eukaryotic cells by type III secretion machines. Nature (2006) 7.49
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol (2001) 5.48
Bacterial invasion: the paradigms of enteroinvasive pathogens. Science (2004) 4.95
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 4.25
MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri lpa invasins. Mol Microbiol (1993) 4.17
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
MR1 presents microbial vitamin B metabolites to MAIT cells. Nature (2012) 3.71
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol (2005) 2.15
Regulation of the antimicrobial response by NLR proteins. Immunity (2011) 2.04
Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol (2005) 1.97
Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med (2012) 1.71
H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J Exp Med (1999) 1.70
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol (2008) 1.45
A gene outside the human MHC related to classical HLA class I genes. Science (1995) 1.34
Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses. J Biol Chem (2011) 1.28
Biochemical features of the MHC-related protein 1 consistent with an immunological function. J Immunol (2003) 1.27
Salmonella gut invasion involves TTSS-2-dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina propria phagocytes. Cell Host Microbe (2012) 1.26
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers. Vaccine (2007) 0.81
LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway. Scand J Immunol (2010) 0.80
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood (2005) 4.64
Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 4.25
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol (2002) 3.78
TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol (2002) 3.28
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
Modulation of Shigella virulence in response to available oxygen in vivo. Nature (2010) 2.96
Optimization of virulence functions through glucosylation of Shigella LPS. Science (2005) 2.81
STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med (2009) 2.72
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med (2007) 2.41
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med (2005) 2.33
Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25
Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity (2013) 2.23
NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol (2009) 2.12
Secretion of type III effectors into host cells in real time. Nat Methods (2005) 2.11
ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol (2009) 2.09
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol (2011) 2.01
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet (2005) 1.99
Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J (2002) 1.99
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Mol Microbiol (2002) 1.90
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol (2009) 1.79
PD-L2 is expressed on activated human T cells and regulates their function. Mol Immunol (2011) 1.79
CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol (2006) 1.77
A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest (2005) 1.77
Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet (2006) 1.74
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet (2001) 1.70
ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J (2007) 1.68
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67
Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat Cell Biol (2003) 1.66
Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche. Cell Host Microbe (2012) 1.66
A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol Microbiol (2005) 1.61
The new species Brucella microti replicates in macrophages and causes death in murine models of infection. J Infect Dis (2010) 1.60
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol Microbiol (2008) 1.55
Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N Engl J Med (2006) 1.54
Commensals, bacterial pathogens and intestinal inflammation: an intriguing ménage à trois. Cell Host Microbe (2008) 1.51
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis (2009) 1.49
Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol (2004) 1.49
Force generation upon T cell receptor engagement. PLoS One (2011) 1.49
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes. Immunity (2008) 1.48
Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner. Eur J Immunol (2013) 1.45
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin Cancer Res (2010) 1.42
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity (2002) 1.39
Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitment. J Cell Sci (2004) 1.37
Specific host genes required for the killing of Klebsiella bacteria by phagocytes. Cell Microbiol (2006) 1.37
Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1. PLoS Pathog (2010) 1.37
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest (2004) 1.33
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol (2009) 1.31
MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol (2013) 1.30
HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J Virol (2009) 1.28
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy (2013) 1.27
Calcium signalling during cell interactions with bacterial pathogens. Biol Cell (2004) 1.25
Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster. Infect Immun (2006) 1.24
Tracking the dynamic interplay between bacterial and host factors during pathogen-induced vacuole rupture in real time. Cell Microbiol (2010) 1.22
Cutting edge: size and diversity of CD4+CD25high Foxp3+ regulatory T cell repertoire in humans: evidence for similarities and partial overlapping with CD4+CD25- T cells. J Immunol (2007) 1.22
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med (2011) 1.22
VAMP7 controls T cell activation by regulating the recruitment and phosphorylation of vesicular Lat at TCR-activation sites. Nat Immunol (2013) 1.21
Src, cortactin and Arp2/3 complex are required for E-cadherin-mediated internalization of Listeria into cells. Cell Microbiol (2007) 1.16
Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol (2009) 1.16
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
Frameshifting by transcriptional slippage is involved in production of MxiE, the transcription activator regulated by the activity of the type III secretion apparatus in Shigella flexneri. Mol Microbiol (2005) 1.15